Rajavelu Esther 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Rajavelu Esther（CIK 1903716）在 1 家公司共报告 7 笔 SEC Form 4 内部人交易（最近一笔 2026-05-06）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-05-06 | Spero Therapeutics, Inc. (SPRO) | Chief Executive Officer, Chief Financial Officer and Chief Business Officer | 卖出 | 25,240 | $63,352 |
| 2026-02-09 | Spero Therapeutics, Inc. (SPRO) | Chief Executive Officer, Chief Financial Officer and Chief Business Officer | 卖出 | 37,101 | $87,558 |
| 2026-02-09 | Spero Therapeutics, Inc. (SPRO) | Chief Executive Officer, Chief Financial Officer and Chief Business Officer | 卖出 | 50,816 | $119,926 |
| 2026-02-04 | Spero Therapeutics, Inc. (SPRO) | Chief Executive Officer, Chief Financial Officer and Chief Business Officer | 买入 | 249,000 | $0 |
| 2026-02-04 | Spero Therapeutics, Inc. (SPRO) | Chief Executive Officer, Chief Financial Officer and Chief Business Officer | 卖出 | 18,442 | $40,572 |
| 2025-11-12 | Spero Therapeutics, Inc. (SPRO) | Chief Executive Officer, Chief Financial Officer and Chief Business Officer | 卖出 | 40,270 | $95,440 |
| 2025-05-06 | Spero Therapeutics, Inc. (SPRO) | Chief Executive Officer, Chief Financial Officer and Chief Business Officer | 买入 | 185,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-05-06